Immune Checkpoint Inhibitor May Change the Standard Treatment of Malignant Pleural Mesothelioma
The immune checkpoint inhibitor durvalumab could become a standard part of first-line mesothelioma treatment if the results of a new…
-
-
T-Cell Immunotherapy Trial Could be Good News for Mesothelioma Patients
The first four mesothelioma patients treated with a new kind of T-cell immunotherapy have responded well with few side effects. … -
Non-Epithelioid Mesothelioma: Immunotherapy Combo Could be the New Standard of Care
Two immunotherapy drugs could become the new standard of care for people with non-epithelioid mesothelioma. All forms of malignant mesothelioma… -
Triple Therapy May Become New First-Line Treatment for Mesothelioma
A combination of three powerful mesothelioma therapies could become a new first-line treatment for mesothelioma if an upcoming clinical trial… -
Common Drugs May Impact Mesothelioma Survival After Immunotherapy
There is new evidence that taking certain common drugs could negatively impact mesothelioma survival after immunotherapy. Drugs such as NSAIDs,… -
First-Line Immunotherapy May Be Better Than Chemo for This Mesothelioma Subtype
A new study suggests that people with sarcomatoid mesothelioma may fare better if they have first-line immunotherapy before considering chemotherapy. … -
Immunotherapy with Durvalumab: Record Survival in Inoperable Mesothelioma
There is new evidence that the immunotherapy drug durvalumab may make chemotherapy more effective for people with inoperable pleural mesothelioma.… -
Opdivo for Mesothelioma Recurrence is Safe and Effective, Study Finds
A new Japanese study appears to show that Opdivo for mesothelioma recurrence after surgery is safe and effective. Opdivo (nivolumab)… -
Rare But Dangerous Side Effects of Opdivo for Mesothelioma
Australian researchers are warning of some rare but deadly side effects of Opdivo (nivolumab) for pleural mesothelioma. They have just… -
Photodynamic Therapy and Immunotherapy: A Powerful Mesothelioma Combo?
Swiss doctors have used a combination of photodynamic therapy and immunotherapy to dramatically shrink mesothelioma tumors in mice. More than…
